176 related articles for article (PubMed ID: 29325499)
1. Insights and barriers to clinical use of serotonin transporter pharmacogenetics in antidepressant therapy.
Stevenson JM
Pharmacogenomics; 2018 Feb; 19(3):167-170. PubMed ID: 29325499
[No Abstract] [Full Text] [Related]
2. Could pharmacogenetics play a role as predictor in treatment of depressive disorders?
Lee MS
World J Biol Psychiatry; 2007; 8(1):2-3. PubMed ID: 17366343
[No Abstract] [Full Text] [Related]
3. 5-HTTLPR rs25531A > G differentially influence paroxetine and fluvoxamine antidepressant efficacy: a randomized, controlled trial.
Kato M; Nonen S; Serretti A; Tetsuo S; Takekita Y; Azuma J; Kinoshita T
J Clin Psychopharmacol; 2013 Feb; 33(1):131-2. PubMed ID: 23288236
[No Abstract] [Full Text] [Related]
4. Systematic review and meta-analysis of serotonin transporter genotype and discontinuation from antidepressant treatment.
Crawford AA; Lewis G; Lewis SJ; Munafò MR
Eur Neuropsychopharmacol; 2013 Oct; 23(10):1143-50. PubMed ID: 23265954
[TBL] [Abstract][Full Text] [Related]
5. The serotonin transporter promoter polymorphism (5-HTTLPR) affects the relation between antidepressant serum concentrations and effectiveness in major depression.
Dreimüller N; Tadić A; Dragicevic A; Boland K; Bondy B; Lieb K; Laux G; Maier W; Müller MJ; Rao ML; Rietschel M; Röschke J; Zill P; Hiemke C
Pharmacopsychiatry; 2012 May; 45(3):108-13. PubMed ID: 22086748
[TBL] [Abstract][Full Text] [Related]
6. Serotonin Transporter Gene Polymorphisms and Selective Serotonin Reuptake Inhibitor Tolerability: Review of Pharmacogenetic Evidence.
Zhu J; Klein-Fedyshin M; Stevenson JM
Pharmacotherapy; 2017 Sep; 37(9):1089-1104. PubMed ID: 28654193
[TBL] [Abstract][Full Text] [Related]
7. Pharmacogenetics in modern psychiatry.
Mihaljević-Peles A; Bozina N; Sagud M
Psychiatr Danub; 2007 Sep; 19(3):231-3. PubMed ID: 17914325
[TBL] [Abstract][Full Text] [Related]
8. From pharmacogenetics to imaging pharmacogenetics: elucidating mechanisms of antidepressant response.
Brandl EJ; Walter H
Pharmacogenomics; 2017 Jul; 18(10):927-930. PubMed ID: 28639501
[No Abstract] [Full Text] [Related]
9. [The influence of genetic variations on the effect of selective serotonin reuptake inhibitors].
Bukh JO; Bock C; Mors NP; Kessing LV
Ugeskr Laeger; 2007 Apr; 169(16):1439-41. PubMed ID: 17484840
[TBL] [Abstract][Full Text] [Related]
10. Association between a functional serotonin transporter promoter polymorphism and citalopram treatment in adult outpatients with major depression.
Hu XZ; Rush AJ; Charney D; Wilson AF; Sorant AJ; Papanicolaou GJ; Fava M; Trivedi MH; Wisniewski SR; Laje G; Paddock S; McMahon FJ; Manji H; Lipsky RH
Arch Gen Psychiatry; 2007 Jul; 64(7):783-92. PubMed ID: 17606812
[TBL] [Abstract][Full Text] [Related]
11. Understanding the pharmacogenetics of selective serotonin reuptake inhibitors.
Fabbri C; Minarini A; Niitsu T; Serretti A
Expert Opin Drug Metab Toxicol; 2014 Aug; 10(8):1093-118. PubMed ID: 24930681
[TBL] [Abstract][Full Text] [Related]
12. The influence of 5-HTTLPR and STin2 polymorphisms in the serotonin transporter gene on treatment effect of selective serotonin reuptake inhibitors in depressive patients.
Smits KM; Smits LJ; Peeters FP; Schouten JS; Janssen RG; Smeets HJ; van Os J; Prins MH
Psychiatr Genet; 2008 Aug; 18(4):184-90. PubMed ID: 18628680
[TBL] [Abstract][Full Text] [Related]
13. [Prediction of antidepressant response to milnacipran and fluvoxamine using pharmacogenetical methods].
Higuchi H
Nihon Shinkei Seishin Yakurigaku Zasshi; 2010 Apr; 30(2):71-6. PubMed ID: 20491280
[TBL] [Abstract][Full Text] [Related]
14. Pharmacogenetics of selective serotonin reuptake inhibitors in pediatric depression and anxiety.
Kronenberg S; Frisch A; Rotberg B; Carmel M; Apter A; Weizman A
Pharmacogenomics; 2008 Nov; 9(11):1725-36. PubMed ID: 19018726
[TBL] [Abstract][Full Text] [Related]
15. Pharmacogenetics and the serotonin transporter in late-life depression.
Gerretsen P; Pollock BG
Expert Opin Drug Metab Toxicol; 2008 Dec; 4(12):1465-78. PubMed ID: 19040324
[TBL] [Abstract][Full Text] [Related]
16. Monoamine transporter gene polymorphisms and antidepressant response in koreans with late-life depression.
Kim H; Lim SW; Kim S; Kim JW; Chang YH; Carroll BJ; Kim DK
JAMA; 2006 Oct; 296(13):1609-18. PubMed ID: 17018806
[TBL] [Abstract][Full Text] [Related]
17. Common selective serotonin reuptake inhibitor side effects in older adults associated with genetic polymorphisms in the serotonin transporter and receptors: data from a randomized controlled trial.
Garfield LD; Dixon D; Nowotny P; Lotrich FE; Pollock BG; Kristjansson SD; Doré PM; Lenze EJ
Am J Geriatr Psychiatry; 2014 Oct; 22(10):971-9. PubMed ID: 24021217
[TBL] [Abstract][Full Text] [Related]
18. Moderation of antidepressant response by the serotonin transporter gene.
Huezo-Diaz P; Uher R; Smith R; Rietschel M; Henigsberg N; Marusic A; Mors O; Maier W; Hauser J; Souery D; Placentino A; Zobel A; Larsen ER; Czerski PM; Gupta B; Hoda F; Perroud N; Farmer A; Craig I; Aitchison KJ; McGuffin P
Br J Psychiatry; 2009 Jul; 195(1):30-8. PubMed ID: 19567893
[TBL] [Abstract][Full Text] [Related]
19. Pharmacogenetics of selective serotonin reuptake inhibitors (SSRI): A serotonin reuptake transporter (SERT)-based approach.
Sreeja V; Jose A; Patel S; Menon B; Athira KV; Chakravarty S
Neurochem Int; 2024 Feb; 173():105672. PubMed ID: 38157886
[TBL] [Abstract][Full Text] [Related]
20. Pharmacogenomics and antidepressant drugs.
Binder EB; Holsboer F
Ann Med; 2006; 38(2):82-94. PubMed ID: 16581694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
